Stay informed with this week's highlights in psychiatric advancements, including emergency psychiatry, a major update on Cobenfy, new partnerships for better treatments, and more.

In this CME article, explore the complexities of Parkinson disease, focusing on neuropsychiatric symptoms, their prevalence, and effective treatment strategies for improved patient care.

Resilience is dynamic and modifiable and is associated with positive rehabilitation outcomes following brain injury. Engaging patients in interventions to develop and strengthen resilience may improve rehabilitation outcomes by promoting psychosocial adjustment, mitigating emotional distress, and enhancing community participation.

"That life is real and if you can survive it, well, survive it well with love and art and meaning given where meaning’s scarce."

Pope Francis' legacy intertwines mental health advocacy with spirituality, promoting compassion and reducing stigma in the Church and beyond.

New findings from the RESTORE-LIFE study suggest the potential benefits of VNS treatment in patients with DTD.

Emergency psychiatry navigates complex ethical dilemmas, balancing patient safety, autonomy, and confidentiality in high-stakes situations.

Breaking with the past—a history of the manifesto.

Dr Sue Varma shares her journey in psychiatry and media, promoting practical optimism and combating misinformation in mental health discussions.

Exploring the complexities of assisted dying, ethical dilemmas, and the evolving role of physicians in end-of-life decisions.

Wisdom: in the eyes of the beholder?

Here are 3 simple steps to help reduce physician suicide.

EmPATH units revolutionize emergency psychiatry, offering rapid, compassionate care for behavioral health crises and improving community outcomes.

Transneural Therapeutics launches innovative neuroplastogens to revolutionize treatment for neuropsychiatric diseases, promising safer, effective alternatives to psychedelics.

The debate on physician-assisted suicide challenges medical ethics, emphasizing the role of doctors in providing care, not death, while navigating societal pressures.

Cobenfy as an adjunctive treatment to atypical antipsychotics did not reach the primary endpoint of the phase 3 ARISE trial, or a statistically significant difference compared with placebo with an atypical antipsychotic.

Physicians are less likely to get treatment for physical and mental issues, which may be driving higher rates of suicide.

Emergency departments face unique challenges in providing psychiatric care for individuals with intellectual and developmental disabilities, impacting wait times and overall experience.

Cybin partners with Osmind to enhance mental health treatment access, focusing on innovative therapies for depression and anxiety disorders.

Happy Earth Day! What terms should we be using to describe our current climate situation? Let’s decide.

A recent study reveals some alarming statistics about physician suicide. What interventions can help reduce this trend?

The first patient has been dosed in MindMed’s phase 3 Emerge study evaluating the efficacy of MM120 ODT.

2025: one of the most consequential years ever for emergency psychiatry.

The use of arts in psychiatry has been a healing and therapeutic tool of care, though unfortunately decimated over the years by cuts in funding.